
FDA approves a powder delivery system combining a corticosteroid and a LABA.
FDA approves a powder delivery system combining a corticosteroid and a LABA.
Since pharmacists dispense potentially harmful medications, it is critical that we also impart information about poison control.
Letters, e-mails, comments, and posts from Drug Topics readers
Cost is the primary non-efficacy factor that drives decisions on which pain medications to include in formularies, according to a survey that included hospital pharmacy directors.
Who sez older pharmacists should be put out to pasture? Not these guys - they're too busy working to consider the possibility.
From controlled substances to retail chains in trouble and back to controlled substances, Drug Topics readers found plenty to talk about during the month of April.
An eight-week regimen of ledipasvir-sofosbuvir was highly effective in treating non-cirrhotic HCV patients with genotype infection.
Nearly one-third of the ADHD-diagnosed foster-care youth received atypical antipsychotics regardless of age group.
The sublingual tablet provides a new treatment option for patients who decline allergy shots
Study finds that targeting the pharmacy service to patients who are most likely to benefit is important.
“Healthcare professionals should consider whether the benefits of Doribax treatment are likely to exceed its potential risks in patients who develop pneumonia while on ventilators,” says FDA.
There is no testimony without tests. How are we handling ours?
Drugs dispensed by physicians are far more expensive than those dispensed by pharmacies. And there are other issues.
The fight over whether pharmacists serve "patients" or "customers" continues. And now there's a new question: How come a major national pharmacy organization has no opinion?
Pharmacies that don't use social media will soon go the way of the dinosaur. Here are six tips for making these modalities work for you.
By maintaining a strong knowledge base about HCV infection and management, pharmacists can be a resource to providers and patients alike.
Things aren't as simple as the DEA would have us believe.
Pharmacists and consumers alike need to educate themselves about the proper use of these products, taken either alone or with Rx medications.
As opposition to execution drugs grows, manufacturers are cutting off supplies and compounding pharmacies are under pressure.
Some early adopters - well, beta testers - give us the lowdown on current and future applications of Google Glass in pharmacy.
Conditions targeted by the first guidelines geared specifically to women include migraine, high blood pressure, preeclampsia, and atrial fibrillation.
Once-daily simeprevir should be used in combination with peginterferon alpha and ribavirin. It is not a monotherapy.
Groundbreaking new therapies for HCV are now available. As experts in screening and treatment guidelines, pharmacists can lead in managing these new options for patient care.
Letters, e-mails, comments, and posts from Drug Topics readers
New Rx, formulations, indications, and generics